Glycine vs Placebo for the Schizophrenia Prodrome

NCT00291226 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia Prodrome

Interventions

DRUG: Glycine
DRUG: Placebo

Sponsor

Yale University

Collaborators

[object Object]
[object Object]